Albany, NY -- (SBWIRE) -- 01/19/2016 -- Mice models have long been the backbone of fundamental and applied research in life sciences and continues to grow at a rapid rate. The mice model market has transformed since 2001, the year rodent genome was mapped. Mice models have a wide array of applications such as basic research, developing new therapeutic strategies for the treatment of human diseases, drug discovery and development research (such as target characterization, drug screening, and toxicity and safety evaluation), and preclinical studies of drug efficacy. Hundreds of mice models have been developed to study diseases such as cancer, Huntington's, Parkinson's, Duchenne and Becker muscular dystrophy, and amyotrophic lateral sclerosis (ALS). In the last 25 years, around 80% of discoveries in the biomedical research has been linked to research on mice.

Complete Report with TOC @ http://www.mrrse.com/mice-model-market

The global mice model market was valued at USD 1,008.1 million in 2014 and is projected to reach USD 1,749.3 million in 2023, expanding at a CAGR of 6.4% from 2015 to 2023. Major factor boosting the growth of the market is the growing application of mice models not only in the field of basic research, but also in applied field of drug development and discovery. Development of mice models of human diseases has progressed rapidly in the past few years. Mice model has become indispensable in the evaluation of established and experimental treatment strategies, especially in cancer, cardiovascular diseases, metabolic anomalies, and neurological disorders. Mice model applications in drug discovery include development of new therapeutic strategies for the treatment of human diseases, target identification and validation, drug screening and lead optimization, and toxicity and safety screening. Furthermore, advancements in genetic engineering assisting in evaluating drug mechanism of action and its responses are expected to impact the growth of the drug discovery market. On the other hand, factors such as stringent regulatory framework that require precise control on use of animals in laboratories, rising concern on animal cruelty, and ethical concerns over the use of animals could negatively impact market growth.

The mice model market has been segmented into three major categories: model type, specialty, and services. Based on model type, inbred was the largest segment of the global mice model market in 2014 due to advantages such as cost effectiveness and data reproducibility. Metabolic & regulatory diseases was the largest specialty segment of the mice model market in terms of revenue in 2014. The segment accounted for 29.6% share of the market in 2014. The mice model services market is anticipated to expand at a CAGR of 7.3% from 2015 to 2023. The cryopreservation and cryorecovery services segment would expand at the highest growth rate during the forecast period as it requires less investment to maintain mice strain for a longer time.

Based on geography, the mice model market has been segmented into North America, Europe, Asia Pacific, Latin America, MENA, and Rest of the World (RoW). North America was the largest market for mice model in 2014. Ongoing robust research activities for the development of drugs and biologics and presence of major pharmaceutical and biotechnology companies in the region are some of the factors responsible for the dominance of the region. Europe held the second largest share of the global mice model market in terms of revenue in 2014. Asia Pacific is expected to be the fastest growing market for mice model during the forecast period from 2015 to 2023. This high growth is primarily due to improving economic condition in countries such as India and China, and increasing number of academic and research, and contract research organizations in Asia Pacific. Japan, China, Australia, and India are the major markets in Asia Pacific that offer immense opportunities to companies in the mice model market. Continuous increase in biomedical research expenditure in China and India are expected to play a key role in fueling the growth in these markets. The market in MENA, Rest of the World (RoW) and Latin America would also grow significantly due to increasing public and private investment in biomedical researches. In addition, factors such as improving health care infrastructure, rising awareness, and flexible regulatory requirements in the region are driving the mice model market.

Request a Free Sample Copy of the Report @ http://www.mrrse.com/sample/353

Key players operating in the global mice model market include Charles River Laboratories, Crescendo Biologics Limited, Deltagen, Inc., genOway S.A., Harlan Laboratories, Inc., ImmunoGenes AG, Taconic Biosciences, Inc., Lexicon Pharmaceuticals, SAGE Labs, The Jackson Laboratory, and TransGenic, Inc.

About MRRSE
MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unions, governments, and embassies.